Does UPADACITINIB Cause Myalgia? 298 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 298 reports of Myalgia have been filed in association with UPADACITINIB (Rinvoq). This represents 0.5% of all adverse event reports for UPADACITINIB.
298
Reports of Myalgia with UPADACITINIB
0.5%
of all UPADACITINIB reports
2
Deaths
51
Hospitalizations
How Dangerous Is Myalgia From UPADACITINIB?
Of the 298 reports, 2 (0.7%) resulted in death, 51 (17.1%) required hospitalization, and 2 (0.7%) were considered life-threatening.
Is Myalgia Listed in the Official Label?
Yes, Myalgia is listed as a known adverse reaction in the official FDA drug label for UPADACITINIB.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Myalgia?
ATORVASTATIN (7,155)
EVOLOCUMAB (5,061)
ROSUVASTATIN (3,958)
SIMVASTATIN (3,919)
ADALIMUMAB (3,134)
DUPILUMAB (3,064)
DENOSUMAB (2,965)
LEVOTHYROXINE (2,467)
CIPROFLOXACIN (2,291)
EZETIMIBE (2,066)
Which UPADACITINIB Alternatives Have Lower Myalgia Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL